How to buy LHC Group stock - 13 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy LHC Group stock

Own LHC Group stock in just a few minutes.

LHC Group, Inc is a medical care facilities business based in the US. LHC Group shares (LHCG) are listed on the NASDAQ and all prices are listed in US Dollars. LHC Group employs 14,341 staff and has a trailing 12-month revenue of around USD$2.1 billion.

How to buy shares in LHC Group

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for LHC Group. Find the stock by name or ticker symbol: LHCG. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until LHC Group reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of LHC Group, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of LHC Group. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

LHC Group share price

Use our graph to track the performance of LHCG stocks over time.

LHC Group shares at a glance

Information last updated 2021-04-09.
52-week rangeUSD$116.26 - USD$236.81
50-day moving average USD$191.443
200-day moving average USD$206.2428
Wall St. target priceUSD$251.8
PE ratio 56.3258
Dividend yield N/A (0%)
Earnings per share (TTM) USD$3.56

Buy LHC Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy LHC Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is LHC Group under- or over-valued?

Valuing LHC Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LHC Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

LHC Group's P/E ratio

LHC Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 56x. In other words, LHC Group shares trade at around 56x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

LHC Group's PEG ratio

LHC Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.2427. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LHC Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

LHC Group's EBITDA

LHC Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$201.2 million.

The EBITDA is a measure of a LHC Group's overall financial performance and is widely used to measure a its profitability.

LHC Group financials

Revenue TTM USD$2.1 billion
Operating margin TTM 8.72%
Gross profit TTM USD$812.8 million
Return on assets TTM 4.86%
Return on equity TTM 8.75%
Profit margin 5.41%
Book value $49.094
Market capitalisation USD$6.3 billion

TTM: trailing 12 months

Shorting LHC Group shares

There are currently 921,577 LHC Group shares held short by investors – that's known as LHC Group's "short interest". This figure is 25.2% up from 735,888 last month.

There are a few different ways that this level of interest in shorting LHC Group shares can be evaluated.

LHC Group's "short interest ratio" (SIR)

LHC Group's "short interest ratio" (SIR) is the quantity of LHC Group shares currently shorted divided by the average quantity of LHC Group shares traded daily (recently around 220472.96650718). LHC Group's SIR currently stands at 4.18. In other words for every 100,000 LHC Group shares traded daily on the market, roughly 4180 shares are currently held short.

However LHC Group's short interest can also be evaluated against the total number of LHC Group shares, or, against the total number of tradable LHC Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case LHC Group's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 LHC Group shares in existence, roughly 30 shares are currently held short) or 0.037% of the tradable shares (for every 100,000 tradable LHC Group shares, roughly 37 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against LHC Group.

Find out more about how you can short LHC Group stock.

LHC Group share dividends

We're not expecting LHC Group to pay a dividend over the next 12 months.

LHC Group share price volatility

Over the last 12 months, LHC Group's shares have ranged in value from as little as $116.26 up to $236.81. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LHC Group's is 0.3795. This would suggest that LHC Group's shares are less volatile than average (for this exchange).

LHC Group overview

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. Its Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The company's Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. Its Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates institutional pharmacy and other non-related facilities, nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The company's Healthcare Innovations (HCI) Services segment provides strategic health management services to accountable care organizations. As of December 31, 2020, it operated 537 home health services locations, 120 hospice locations, 124 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 12 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site